How moving to the US completely changed the business model of NuvoAir Medical? An interview with Lorenzo Consoli, Founder and CEO.
Written by Stela Nikolova on March 24, 2024
Chronic respiratory diseases affect approximately 500 million individuals worldwide and are often linked with heart failure. In the United States, COPD and Chronic Heart Failure (CHF) alone account for a combined annual cost exceeding $100 billion. In light of this significant impact, how does NuvoAir Medical redefine chronic heart and lung disease management with their
Learn more...